MedTrace Logo

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

NCT00301145 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2013-12-19

No results posted yet for this study

Summary

RATIONALE: Varenicline tartrate may help people quit smoking by decreasing the symptoms of nicotine withdrawal. It is not yet known whether varenicline tartrate is more effective in helping people stop smoking when given together with a telephone-based counseling program, and Internet-based counseling program, or both programs.

PURPOSE: This randomized clinical trial is studying how well giving varenicline tartrate together with a telephone-based counseling program and/or an Internet-based counseling program works in helping adults stop smoking.

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BEHAVIORAL

smoking cessation intervention

DRUG

varenicline

OTHER

counseling intervention

OTHER

internet-based intervention

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SRI International

    lead INDUSTRY

Principal Investigators

  • Gary E. Swan, PhD · SRI International

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-06-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301145 on ClinicalTrials.gov